Symbicort Turbuhaler (Lyfjaver) Noregur Innöndunarduft 160/4,5 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

symbicort turbuhaler (lyfjaver) noregur innöndunarduft 160/4,5 míkróg/skammt

lyfjaver ehf. - budesonidum inn; formoterolum inn fúmarat - innöndunarduft - 160/4,5 míkróg/skammt

Bufomix Easyhaler Innöndunarduft 160 míkróg/4,5 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

bufomix easyhaler innöndunarduft 160 míkróg/4,5 míkróg/skammt

orion corporation - budesonidum inn; formoterolum fúmarat - innöndunarduft - 160 míkróg/4,5 míkróg/skammt

Bufomix Easyhaler Innöndunarduft 320 míkróg/9 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

bufomix easyhaler innöndunarduft 320 míkróg/9 míkróg/skammt

orion corporation - budesonidum inn; formoterolum fúmarat - innöndunarduft - 320 míkróg/9 míkróg/skammt

Symbicort forte Turbuhaler Innöndunarduft 320/9 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

symbicort forte turbuhaler innöndunarduft 320/9 míkróg/skammt

astrazeneca a/s - budesonidum inn; formoterolum fúmarat - innöndunarduft - 320/9 míkróg/skammt

Symbicort mite Turbuhaler Innöndunarduft 80/4,5 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

symbicort mite turbuhaler innöndunarduft 80/4,5 míkróg/skammt

astrazeneca a/s - budesonidum inn; formoterolum fúmarat - innöndunarduft - 80/4,5 míkróg/skammt

Symbicort Turbuhaler Innöndunarduft 160/4,5 míkróg/skammt Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

symbicort turbuhaler innöndunarduft 160/4,5 míkróg/skammt

astrazeneca a/s - budesonidum inn; formoterolum fúmarat - innöndunarduft - 160/4,5 míkróg/skammt

Trixeo Aerosphere Evrópusambandið - íslenska - EMA (European Medicines Agency)

trixeo aerosphere

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Riltrava Aerosphere Evrópusambandið - íslenska - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Pulmicort Dreifa í eimgjafa 0,125 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,125 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,125 mg/ml

Pulmicort Dreifa í eimgjafa 0,25 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,25 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,25 mg/ml